Source:http://linkedlifedata.com/resource/pubmed/id/17606427
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-7-3
|
pubmed:abstractText |
The objective of this research was to investigate the clinical performance of COBAS AMPLICOR hepatitis C virus (HCV) test version 2.0 Assays (CA V2.0). Eight serial samples with standard HCV ribonucleic acid (RNA) concentration and 10 times serial dilution of the 500 IU/mL samples were tested in triplicate by CA V2.0 (the limit of detection was 50 IU/mL). HCV RNA was investigated with CA V2.0 in 220 specimens from 100 chronic hepatitis C (CHC) patients, 60 chronic hepatitis B patients, and 60 healthy blood donors. The sensitivity was 99% and the specificity was 98.3%. Sera of 84 naïve CHC patients receiving standard interferon plus ribavirin for 24 weeks were tested by CA V2.0 and CA V1.0 at weeks 2, 4 and 8. The positive detection rates of CA V2.0 were significantly higher than CA V1.0 at week 2 (60.7% vs. 51.2%; p < 0.01) and week 8 (27.4% vs. 21.4%; p < 0.05). At weeks 2, 4 and 8, the positive predictive values were 90.91%, 83.02% and 78.69% with CA V2.0, and 90.24%, 82.14% and 72.73% with CA V1.0. The negative predictive values were 58.82%, 77.42% and 86.96% with CA V2.0, and 67.44%, 82.14% and 83.33% with CA V1.0. However, there was no significant difference between CA V2.0 and CA V1.0 for predicting sustained virologic response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1607-551X
|
pubmed:author |
pubmed-author:ChangWen-YuWY,
pubmed-author:ChenShinn-CherngSC,
pubmed-author:ChuangWan-LongWL,
pubmed-author:DaiChia-YenCY,
pubmed-author:HouNai-JenNJ,
pubmed-author:HsiehMing-YenMY,
pubmed-author:HsiehMing-YuhMY,
pubmed-author:HuangJee-FuJF,
pubmed-author:LeeLi-PoLP,
pubmed-author:LinZu-YauZY,
pubmed-author:WangLiang-YenLY,
pubmed-author:YangJeng-FuJF,
pubmed-author:YuMing-LungML
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
332-8
|
pubmed:meshHeading |
pubmed-meshheading:17606427-Hepatitis C, Chronic,
pubmed-meshheading:17606427-Humans,
pubmed-meshheading:17606427-Interferons,
pubmed-meshheading:17606427-RNA, Viral,
pubmed-meshheading:17606427-Reproducibility of Results,
pubmed-meshheading:17606427-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17606427-Ribavirin,
pubmed-meshheading:17606427-Sensitivity and Specificity
|
pubmed:year |
2007
|
pubmed:articleTitle |
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0.
|
pubmed:affiliation |
Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|